215 related articles for article (PubMed ID: 23216938)
1. Chronic fondaparinux use in a hemodialysis patient with heparin-induced thrombocytopenia type II and extracorporeal circuit thrombosis-a case report and review of the literature.
Brown P; Jay R; Fox A; Oliver M
Hemodial Int; 2013 Jul; 17(3):444-9. PubMed ID: 23216938
[TBL] [Abstract][Full Text] [Related]
2. Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience.
Grouzi E; Kyriakou E; Panagou I; Spiliotopoulou I
Clin Appl Thromb Hemost; 2010 Dec; 16(6):663-7. PubMed ID: 19825921
[TBL] [Abstract][Full Text] [Related]
3. Heparin-induced thrombocytopenia in a hemodialysis patient treated with fondaparinux: nephrologists between two fires.
Solak Y; Demircioglu S; Polat I; Biyik Z; Gaipov A; Acar K; Turk S
Hemodial Int; 2013 Apr; 17(2):320-3. PubMed ID: 22631215
[TBL] [Abstract][Full Text] [Related]
4. [Patient who developed heparin-induced thrombocytopenia type II after 24 years on hemodialysis].
Gavranić BB; Basić-Jukić N; Kes P
Acta Med Croatica; 2012 Oct; 66 Suppl 2():68-71. PubMed ID: 23513420
[TBL] [Abstract][Full Text] [Related]
5. Treatment of heparin-induced thrombocytopenia with fondaparinux.
Harenberg J; Jörg I; Fenyvesi T
Haematologica; 2004 Aug; 89(8):1017-8. PubMed ID: 15339691
[TBL] [Abstract][Full Text] [Related]
6. Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
Wellborn-Kim JJ; Mitchell GA; Terneus WF; Stowe CL; Malias MA; Sparkman GM; Hanson GW
Am J Health Syst Pharm; 2010 Jul; 67(13):1075-9. PubMed ID: 20554593
[TBL] [Abstract][Full Text] [Related]
7. Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia.
Efird LE; Kockler DR
Ann Pharmacother; 2006; 40(7-8):1383-7. PubMed ID: 16788093
[TBL] [Abstract][Full Text] [Related]
8. Heparin-induced thrombocytopenia due to heparin lock in a hemodialysis patient: a case report.
Chan KM; Cheung CY; Chau KF
Hemodial Int; 2014 Apr; 18(2):555-8. PubMed ID: 24405989
[TBL] [Abstract][Full Text] [Related]
9. [Fondaparinux treatment in heparin induced thrombocytopenia:a case report].
Ozsu S; Korkmaz A; Bülbül Y; Oztuna F; Ozlü T
Tuberk Toraks; 2011; 59(2):178-83. PubMed ID: 21740395
[TBL] [Abstract][Full Text] [Related]
10. Successful use of fondaparinux in a child with heparin-induced thrombocytopenia.
Tokgoz H; Caliskan U; Demir M
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):769-71. PubMed ID: 22964766
[TBL] [Abstract][Full Text] [Related]
11. Fondaparinux in heparin-induced thrombocytopenia.
Gevaert A; Smets H; Vercauteren R
Acta Cardiol; 2013 Oct; 68(5):517-20. PubMed ID: 24283115
[TBL] [Abstract][Full Text] [Related]
12. Heparins, low-molecular-weight heparins, and pentasaccharides.
Dinwoodey DL; Ansell JE
Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464
[TBL] [Abstract][Full Text] [Related]
13. [Heparin induced thrombocytopenia type II after the use of low-molecular weight heparin. Case report and review of the literature].
Franke J; Schaeper O; Kayser R; Mahlfeld K
Unfallchirurg; 2003 Jan; 106(1):77-81. PubMed ID: 12552397
[TBL] [Abstract][Full Text] [Related]
14. Successful use of fondaparinux early after mechanical aortic valve replacement in a patient with a history of heparin-induced thrombocytopenia.
Willenborg KL
Pharmacotherapy; 2014 Jun; 34(6):e55-9. PubMed ID: 24644124
[TBL] [Abstract][Full Text] [Related]
15. Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues.
Blackmer AB; Oertel MD; Valgus JM
Ann Pharmacother; 2009 Oct; 43(10):1636-46. PubMed ID: 19737996
[TBL] [Abstract][Full Text] [Related]
16. Frequency of anti-heparin-PF4 complex antibodies (HIT antibodies) in uremic patients on chronic intermittent hemodialysis.
Matsuo T; Kobayashi H; Matsuo M; Wanaka K; Nakamoto H; Matsushima H; Sakai R
Pathophysiol Haemost Thromb; 2006; 35(6):445-50. PubMed ID: 17565238
[TBL] [Abstract][Full Text] [Related]
17. [Heparin-induced thrombocytopenia syndrome and thrombosis in patients undergoing periodic haemodialysis].
Gregorini G; Bellandi D; Martini G; Volpi R
G Ital Nefrol; 2002; 19(6):672-92. PubMed ID: 12508172
[TBL] [Abstract][Full Text] [Related]
18. Fondaparinux cross-reacts with heparin antibodies in vitro in a patient with fondaparinux-related thrombocytopenia.
Pistulli R; Oberle V; Figulla HR; Yilmaz A; Pfeifer R
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):76-8. PubMed ID: 21076279
[TBL] [Abstract][Full Text] [Related]
19. Fondaparinux as a safe alternative for managing heparin-induced thrombocytopenia in postoperative cardiac surgery patients.
Cegarra-Sanmartín V; González-Rodríguez R; Paniagua-Iglesias P; Santamaría-Ortiz A; Cueva LF; Galán-Serrano J; Moral-García MV
J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1008-12. PubMed ID: 24439171
[TBL] [Abstract][Full Text] [Related]
20. [Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
Seculini Patiño CE; Pascualini MF; Tabares AH
Medicina (B Aires); 2015; 75(5):307-10. PubMed ID: 26502466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
